ATARA BIOTHERAPEUTICS, INC. Proceeds from Stock Options Exercised
ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Proceeds from Stock Options Exercised of $250.00 thousand for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-04.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2016-11-04
- ATARA BIOTHERAPEUTICS, INC. proceeds from stock options exercised for the quarter ending 2016-09-30 was $221.00K, a 35.58% increase year-over-year.
- ATARA BIOTHERAPEUTICS, INC. proceeds from stock options exercised for the quarter ending 2016-06-30 was $15.00K.
- ATARA BIOTHERAPEUTICS, INC. proceeds from stock options exercised for the quarter ending 2016-03-31 was $14.00K.
- ATARA BIOTHERAPEUTICS, INC. proceeds from stock options exercised for the quarter ending 2015-12-31 was $244.00K.
- ATARA BIOTHERAPEUTICS, INC. proceeds from stock options exercised for fiscal 2015 was $439.00K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2016-09-30 | $221.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $236.00K derived: sum of 2 quarters · filed 2016-11-04 | $250.00K 10-Q · filed 2016-11-04 | $494.00K derived: sum of 4 quarters · filed 2016-11-04 |
| 2016-06-30 | $15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $29.00K 10-Q · filed 2016-08-08 | $273.00K derived: sum of 3 quarters · filed 2016-08-08 | $436.00K derived: sum of 4 quarters · filed 2016-11-04 |
| 2016-03-31 | $14.00K 10-Q · filed 2016-05-06 | $258.00K derived: sum of 2 quarters · filed 2016-05-06 | $421.00K derived: sum of 3 quarters · filed 2016-11-04 | |
| 2015-12-31 | $244.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-04 | $407.00K derived: sum of 2 quarters · filed 2016-11-04 | $439.00K 10-K · filed 2016-03-04 | |
| 2015-09-30 | $163.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $195.00K 10-Q · filed 2016-11-04 | ||
| 2015-06-30 | $32.00K 10-Q · filed 2015-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |